Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-214-4 | CAS number: 21109-95-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
There was no evidence of carcinogenic activity (showing no chemical related increase of malignant or benign neoplasms) of barium chloride dihydrate in both sexes of rats that received 500, 1250, and 2500 ppm. Thus, the concentration of 2500 ppm BaCl2 *2 H2O represents a NOAEL (corresponding to Ba doses of 60 and 75 mg/kg bw/d to male and female rats, respectively). The NOAEL was derived by a toxicologist that reviewed the article.
There is no conclusive evidence for any carcinogenic potential of H2S in the public domain, despite that it is well-known that H2S can elicit local effects in the respiratory tract. Upon systemic availability, sulfides are rapidly oxidised and excreted renally as sulfates. Regarding sulfur and sulfates, there is a general opinion that these compounds are essential for life and do not pose a risk for humans.
Thus, in the absence of any conclusive human or animal evidence for any carcinogenic effect, the complete lack of genotoxicity of sulfides, and given the metabolic profile and natural geogenic ubiquitous presence of sulfides in the environment, there is no need for the conduct of a carcinogenicity study for inorganic sulfides.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 74 mg/kg bw/day
- Study duration:
- chronic
- Species:
- rat
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
There is no conclusive evidence for any carcinogenic potential of H2S in the public domain, despite that it is well-known that H2S can elicit local effects in the respiratory tract. Upon systemic availability, sulfides are rapidly oxidised and excreted renally as sulfates. Regarding sulfur and sulfates, there is a general opinion that these compounds are essential for life and do not pose a risk for humans.
Thus, in the absence of any conclusive human or animal evidence for any carcinogenic effect, the complete lack of genotoxicity of sulfides, and given the metabolic profile and natural geogenic ubiquitous presence of sulfides in the environment, there is no need for the conduct of a carcinogenicity study for inorganic sulphides.
Furthermore, there was no evidence of carcinogenic activity (showing no chemical related increase of malignant or benign neoplasms) of barium chloride in both sexes of rats and mice that received 500, 1250, and 2500 ppm. Since read across from barium chloride to barium sulphide is considered to be fully justified there is no need for the conduct of a carcinogenicity study for any barium substances.
Thus, according to Directive EEC 67/548 and to EC Regulation No. 1272/2008, barium sulfide should not be considered to have a carcinogenic potential, and hence no classification or labelling is required.
Additional information
READ ACROSS CONCEPT
Valid studies on carcinogenicity for barium sulfide are not available. Therefore, because of the lack of appropriate experimental data, read-across from studies with H2S and BaCl2is proposed based on the following reasoning:
Read-across to H2S:
The readily water-soluble compound barium sulfide will initially dissociate upon dissolution in water and/or relevant physiological media into barium and sulfide ions.
However, sulfide anions will react with water in a pH-dependant reverse dissociation to form hydrogensulfide anions (HS-) or H2S, respectively, according to the following equation:
H2S ↔ H+ + HS- ↔ 2H+ + S2-
The dissociation behaviour is presented in the Hägg graph reported under IUCLID section 5.1.2 Hydrolysis.
The pKa values for the first and second dissociation steps of H2S are 7.0 and 12.9 (for details, refer to the IUCLID section on dissociation constant), respectively. Therefore, at neutral physiological pH values, hydrogen sulfide in the non-dissociated form (H2S) and the hydrogen sulfide anion (HS-) will be present in almost equimolar proportion, whereas only very small amounts of the sulfide anion (S2-) will be present. Conversely, at gastric pH (pH 1-2), non-dissociated H2S will be the predominant species.
In conclusion, under physiological conditions, inorganic sulfides or hydrogensulfides as well as H2S will dissociate to the respective species relevant to the pH of the physiological medium, irrespective of the nature of the “sulfide”, which is why read-across between these substances and H2S is considered to be appropriate without any restrictions for the purpose of hazard and risk assessment of barium sulfide.
Read-across to Ba(OH)2 and BaCl2, respectively:
Upon dissolution in water and/or physiological media, dissociation of barium sulfide to release Ba2+ions may initially be expected.
However, based on the established fact that barium ions may form poorly soluble species for example with physiologically present carbonate ions, the bioaccessibility/bioavailability may vary between different physiological conditions. Notwithstanding this limitation, it is considered justified to read-across from available data either on barium hydroxide (similar water solubility) and/or barium chloride (higher water solubility), the latter representing a conservative approach). In this context, the water solubility of a substance is used as a first approximation of bioavailability:
- barium chloride is highly water soluble with ca. 375 g/L at 20 °C/pH ca. 6.5 (510.4 g/L at pH 1.5)
- barium hydroxide is also highly water soluble (37.4 g/L at 20 °C/pH > 13).
In comparison, the water solubility of barium sulfide is 73.5 g/L at 20 °C (pH 13.7; saturated solution).
In conclusion, read across from barium chloride and barium hydroxide to barium sulfide is considered as justified since the toxicity of these substances may reasonably be considered to be determined by the availability of barium cations. It is noted that although BaS is a strong base, substantial neutralisation in the gastrointestinal tract at pH-levels of approx. 1.5 – 2 may nevertheless be anticipated.
Barium
According to the NTP study performed 1994 with barium chloride, there was no evidence of carcinogenic activity (showing no chemical related increase of malignant or benign neoplasms) of barium chloride in both sexes of rats and mice that received 500, 1250, and 2500 ppm. Thus, the concentration of 2500 ppm represents a NOAEL (corresponding to barium doses of 60 and 75 mg/kg bw/d to male and female rats, respectively, and 160 and 200 mg/kg bw/d to male and female mice, respectively). Based on this value the NOAEL for BaS is calculated at 74 mg/kg bw/day. No classification of the substance as CMR substance is required.
Sulfides and hydrogen sulfides
An extensive literature search and evaluation programme on animal and human repeated dose toxicity data of sodium sulfide, sodium hydrogensulfide and dihydrogen sulfide has been conducted. However, no adequate data from carcinogenicity studies are available.Therefore, information from other substances related to sulfides is considered for evaluation of the carcinogenic hazard.
Justification for selection of carcinogenicity via oral route endpoint:
Only one study was made available that is considered to fulfil the requirements for the carcinogenic endpoint for barium sulfide. The NTP study was performed with barium chloride dihydrate and read across is considered to be fully justified (see discussion). There is no need to initiate a study with inorganic sulfide, assuming the complete lack of genotoxicity of sulfides, and given the metabolic profile and natural geogenic ubiquitous presence of sulfides in the environment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.